STOCKS TRADE LOWER AS NOVEMBER U.S. JOBS REPORT LARGELY DISAPPOINTS

Report came in mixed, with just 210,000 positions added; unemployment rate falls to pandemic-era low

Merck & Co., Inc. (MRK)

NYSE - Nasdaq Real Time Price. Currency in USD

Add to watchlist

73.11

-0.78

(-1.06%)

As of 02:57PM EST. Market open.

Trade prices are not sourced from all markets

All

Editor's Pick
Yahoo Finance Video
COVID: ‘We need to stop wearing cloth masks and go to N95s for all,’ expert says
Jose Luis Jimenez, University of Colorado at Boulder professor of chemistry and CIRES fellow, joins Yahoo Finance Live to give his expert opinion on where investments in masks and ventilation could aid in lowering COVID transmission rates.
Reuters
UPDATE 1-Merck to supply up to 1 mln courses of COVID-19 pill to Canada
Merck & Co said on Friday it would supply Canada with up to 1 million courses of molnupiravir, its experimental oral antiviral medicine for the treatment of COVID-19. The government of Canada has secured access to 500,000 courses in 2022, with options for up to 500,000 more, pending Health Canada's approval, the company said. Merck said it had filed the final molnupiravir real-time application seeking approval in Canada last month.
Reuters
Merck to supply up to 1 mln courses of COVID-19 pill to Canada
Merck & Co said on Friday it would supply the Canada with up to 1 million courses of molnupiravir, its experimental oral antiviral medicine for the treatment of COVID-19. The government of Canada has secured access to 500,000 courses in 2022, with options for up to 500,000 more, pending Health Canada's approval, the company said.